ArticleFrontiers in oncology2022

A case report of the sustained and rapid response of bevacizumab in a TP53-positive breast cancer and liver metastatic patient through personalized medicine.

Mohammad Reza Eskandarion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.